Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma

Completed

Plain-English translation of NCT02860286 on ClinicalTrials.gov ↗ · Source last updated April 2021 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(16 sites)

United States

University of California, Los Angeles, Los Angeles, California

City of Hope National Medical Center, Los Angeles, California

University of California San Francisco, San Francisco, California

Massachusetts General Hospital, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts